Thomas Birger Riisager

Thomas Birger Riisager is a seasoned executive in the life sciences sector with extensive experience in corporate development, strategy, and business development. As Chief Corporate Development Officer at Theramex since June 2023, Riisager previously held the position of Chief Strategy and Business Development Officer at ESTEVE, where responsibilities included corporate strategy and global business development. Prior roles include Vice President of Corporate Business Development at H. Lundbeck A/S, Partner at Odgers Berndtson, and various leadership positions at Lundbeck focused on M&A and corporate strategic initiatives, including the successful acquisition of Chelsea Therapeutics. Riisager's professional journey is underpinned by a Master's degree in Economics from the University of Copenhagen, contributing to a strong foundation in strategic financial analysis and corporate evaluations.